<

 
Data updated 2025-05-08 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date08732084.2 (espacenet)  (Federated)  (European Patent Register), 20080313
Patent/reg. no. and dateDK/EP 2125698, 20160831
Publication date20091202
Priority no. and dateUS 895049 P, 20070315, US 944399 P, 20070615
EP pub. no. and date EP 2125698 20091202
Effective date
Applicant/ownerAuspex Pharmaceuticals, Inc., 3333 North Torrey Pine Court, Suite 400
La Jolla, CA 92037, US
Applicant ref. no.P59273DK01
InventorWOO, Soon, Hyung, 1261 Liberty Way, Suite C
Vista, CA 92081-8356, US,
GANT, Thomas, G., 1261 Liberty Way, Suite C
Vista, CA 92081-8356, US,
SEPEHR, Sarshar, 1261 Liberty Way, Suite C
Vista, CA 92081-8356, US
RepresentativePlougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK
Opponent
IPC ClassC07B 59/00 (2006.01) , C07C 211/64 (2006.01) , C07C 215/64 (2006.01) , C07C 217/74 (2006.01) , C07D 265/16 (2006.01) 
TitleDEUTERERET d9-VENLAFAXIN
Int. application no.US2008056780
Int. publication no.WO2008140859
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact